Similar Search Results

Patient relevant endpoints in oncology : current issues in the context of early benefit assessment in Germany

Dabisch, Inna; Dethling, Jürgen; Dintsios, … - In: Health economics review 4 (2014) 2, pp. 1-8

, focusing on overall survival as the preferred endpoint in oncology. A taskforce of experienced German outcomes research … external stakeholders. Distinctive features of registration trials in oncology need to be considered when these studies form … clinical trial programs that were developed to be consistent with regulatory guidance, endpoints in oncology are thoroughly …

Persistent link: https://www.econbiz.de/10010528451

Severity index for rheumatoid arthritis and its association with health care costs and biologic therapy use in Turkey

Baser, Onur; Baser, Erdem; Altinbas, Akif; Burkan, … - In: Health economics review 3 (2013) 5, pp. 1-7

Objective: This study aimed to apply the previously validated severity index for rheumatoid arthritis (SIFRA) to prevalent rheumatoid arthritis (RA) groups in Turkey and determine the effect of RA severity on health care costs and biologic use. Methods: This retrospective study used the Turkish...

Persistent link: https://www.econbiz.de/10009755341

Patients’ mobility as an indicator for (in)efficiency : a panel data analysis on Italian health care authorities

Mafrolla, Elsabetta; D'Amico, Eugenio - In: Health economics review 3 (2013) 3, pp. 1-13

This paper investigates the influence of internal managerial patterns of heath care authorities on the decision of patients to migrate towards different health care organizations to avail treatments. The efficiency and productivity issues are analyzed, considering the (passive) migration as a...

Persistent link: https://www.econbiz.de/10009755345

Forgone care and financial burden due to out-of-pocket payments within the German health care system

Bremer, Patrick - In: Health economics review 4 (2014) 36, pp. 1-9

Background: The amount of out-of-pocket (OOP) payments within the German health care system has risen steadily within the last years. OOP payments aim to strengthen patients' cost awareness and try to restrict the demand on medical necessary treatments. However, besides the intended decline of...

Persistent link: https://www.econbiz.de/10010526631

Early health economic evaluation of the future potential of next generation artificial vision systems for treating blindness in Germany

Schwander, Bjoern - In: Health economics review 4 (2014) 27, pp. 1-10

The next generation of artificial vision devices (AVDs), which is currently developed in pre-clinical settings, has the potential to improve the vision of blind patients with retinitis pigmentosa (RP) in a manner that they will be categorized as visual impaired but no more as blind. This...

Persistent link: https://www.econbiz.de/10010526936

Requirements for benefit assessment in Germany and England : overview and comparison

Ivandic, Victor - In: Health economics review 4 (2014) 12, pp. 1-14

Background: This study compared the methodological requirements for early health technology appraisal (HTA) by the Federal Joint Committee/Institute for Quality and Efficiency in Health Care (G-BA/IQWiG; Germany) and the National Institute for Health and Care Excellence (NICE; England). Methods:...

Persistent link: https://www.econbiz.de/10010528485

Is healthcare a "necessity" or "luxury"? : an empirical evidence from public and private sector analyses of South-East Asian countries?

Khan, Jahangir A. M.; Mahumud, Rashidul Alam - In: Health economics review 5 (2015) 3, pp. 1-9

South-East Asian Regional (SEAR) countries range from low- to middle-income countries and have considerable differences in mix of public and private sector expenditure on health. This study intends to estimate the income-elasticities of healthcare expenditure in public and private sectors...

Persistent link: https://www.econbiz.de/10010530062

The Role of decision-analytic modelling in German health technology assessments

Kuhlmann, Alexander; Treskova, Marina; Braun, Sebastian; … - In: Health economics review 5 (2015) 7, pp. 1-7

Background: Decision-analytic modelling (DAM) has become a widespread method in health technology assessments (HTA), but the extent to which modelling is used differs among international HTA institutions. In Germany, the use of DAM is optional within HTAs of the German Institute of Medical...

Persistent link: https://www.econbiz.de/10010530072

How much does community-based targeting of the ultra-poor in the health sector cost? : novel evidence from Burkina Faso

Beaugé, Yvonne; Koulidiati, Jean-Louis; Ridde, Valéry; … - In: Health economics review 8 (2018) 19, pp. 1-11

Background: Targeting efforts aimed at increasing access to care for the poorest by reducing to a minimum or completely eliminating payments at point of use are increasingly being adopted across low and middle income countries, within the framework of Universal Health Coverage policies. No...

Persistent link: https://www.econbiz.de/10011896552

Overcoming resistance against managed care : insights from a bargaining model

Ehlert, Andree; Wein, Thomas; Zweifel, Peter - In: Health economics review 7 (2017) 19, pp. 1-9

Recent healthcare reforms have sought to increase efficiency by introducing managed care (MC) while respecting consumer preferences by admitting choice between MC and conventional care. This article proposes an institutional change designed to let German consumers choose between the two settings...

Persistent link: https://www.econbiz.de/10011668893